The Supreme Court on Wednesday refused to let the Trump administration begin taking hormone therapy, surgery and social accommodations away from transgender people in federal prison. The order carries no explanation and says only that Justices Clarence Thomas and Samuel Alito would have granted the request, an apparent 7-2 split. The coverage so far reports the vote. It says little about what the seven left standing: a federal judge’s finding that the Bureau of Prisons ran this care for nearly a decade under its own clinical guidelines, then wrote a policy that cites zero evidence from its own doctors and no security incident from its own prisons.
That finding is in the record because the Bureau’s lawyers could not point to anything else. Judge Royce Lamberth put it plainly in his June 17 memorandum order: “Despite providing gender-affirming care to inmates in its custody for years, the government cites in the Program Statement zero evidence from its own medical or mental health professionals to support its conclusions.” The justices did not adopt those words. They did decline to disturb the injunction that rests on them.
What the Order Says and Does Not Say
It is a one-line denial of an emergency application, which is the shortest form of a Supreme Court ruling. There is no majority opinion, no reasoning and no signal about how the Court would rule on the merits. Thomas and Alito are the only justices noted as willing to grant the stay, so the other seven either agreed with the lower courts or saw no emergency worth overriding them. We cannot tell which, and anyone who says they can is guessing.
What the order does decide is timing. Lamberth’s preliminary injunction stays in force while the case, Kingdom v. Trump, proceeds in the district court. The D.C. Circuit had already voted 2-1 on September 18 to leave the injunction in place. Solicitor General D. John Sauer then took the fight to the Supreme Court, arguing that the injunction “nullifies” the Bureau’s judgment that the change was “necessary to maintain institutional security.” The Court, without saying why, left the injunction in place.
The Policy the Bureau Wanted to Start
Program Statement 5260.01, issued February 19, 2026, is the policy at issue. It bars the Bureau from providing sex-trait surgery, orders staff to take back “social accommodations,” and tells medical staff not to start hormone therapy for anyone who is not already on it. For people currently taking hormones, it requires “a tapering plan.” For people who “recently begun receiving hormones,” the tapering plan “will include a rapid discontinuation.” NBC puts the number of people affected at roughly 1,000 transgender inmates in federal custody, and the class in the case covers anyone in Bureau custody with a gender dysphoria diagnosis, now or in the future.
The text is blunt about what replaces the care. Mental health services stay, and the Bureau would treat gender dysphoria with psychotherapy and psychotropic medication. Lamberth recorded the plaintiffs’ medical evidence that untreated gender dysphoria raises the risk of depression, self-harm and suicidality, and wrote that the defendants “do not contest that gender dysphoria exists.” The fight was never about whether the diagnosis exists. It was about whether the Bureau had a reason to stop treating it.
Nearly a Decade of the Bureau’s Own Records
The Bureau first issued clinical guidelines for gender dysphoria in 2017, updated them periodically to align more closely with community standards, and last revised them in 2023 to include hormone therapy, social accommodations and surgery when clinically indicated. It also ran a Transgender Clinical Care Team of physicians, pharmacists and social workers. Above that sat a Transgender Executive Council, the “decisionmaking body on all issues affecting the transgender population,” and Lamberth noted its membership: senior correctional leaders and the Bureau’s senior psychologist, psychiatrist, medical administrator and security expert.
Read that list again. A security expert sat on the body that governed this care for years. If providing hormones to inmates had produced the security problems the government now cites, we would expect that council to have seen them. Lamberth found the 43-page policy memo supporting the new rule does not meaningfully discuss that experience. The government told the court that officials who ran the old policy helped write the new one. Lamberth found that claim came “solely from the declaration of BOP Medical Director,” not from the Program Statement or the administrative record.
The Security Claim With Nothing Under It
Sauer’s filing leans on institutional security, which is the one argument that sounds like an emergency. The judge looked for the evidence and reported what he found: the government “does not point the Court to evidence that gender-affirming care was ineffective or harmful to its own inmates diagnosed with gender dysphoria, or that providing this care previously led to security concerns at BOP facilities.” The agency produced a 3,000-page administrative record, and the government did not point the court to an incident.
An emergency application asks the Court to find that the government will suffer harm if it waits. The harm claimed was security risk from a practice the Bureau had followed since 2017, and the agency’s own files did not record the risk. We think that is why seven justices did not need to write anything. When the stated emergency is contradicted by the applicant’s own history, the order writes itself.
A Policy Reverse Engineered From an Executive Order
The most damaging passage in Lamberth’s opinion is not about medicine. It compares two sentences. The Program Statement says its intent “is for federal funds to not be expended for any medical procedure, treatment, or drug for the purpose of conforming an inmate’s appearance to that of the opposite sex.” That language, the judge wrote, “comes directly from EO 14168, a fact the Program Statement acknowledges directly.” The Bureau insisted that it “adopts this policy independently” of the executive order after about twelve months of study.
Lamberth was not convinced and found it “more likely, given the record before the Court, that the government disregarded significant evidence in its possession to reach the EO’s mandated result.” Twelve months of work did not help, he wrote, because “no length of consideration can convince the Court that a policy is anything other than pretext when the agency has not demonstrated that it considered the relevant evidence.” This is a finding that the administration decided the answer first and built the file afterward. It is a preliminary finding, and the government disputes it. It is also the finding the Supreme Court just declined to freeze.
The Narrow Ground Under the Win
Here is the second-order problem. Lamberth ruled on the Administrative Procedure Act, not the Eighth Amendment. He wrote that he was leaving the plaintiffs’ constitutional claims “for another day,” because the policy failed as arbitrary and capricious agency action. That is a procedural defect, and procedural defects can be repaired. A Bureau that wants this policy can try again with a record that discusses its own history, names its security incidents if it has any, and quotes its own clinicians.
So the incentive created by this order is not that the policy is dead. It is that the next version will arrive better documented, and the next judge will face a harder question. The people in custody get months of continued care, which matters enormously to each of them, but the legal fight over the policy has barely started. We would not read seven justices declining a stay as a view on whether the Constitution protects this care.
Why the Contrast With July Matters
Nearly four months ago the same Court upheld transgender athlete bans 6-3 in a ruling we described as redefining sex under Title IX. Anyone who read that decision as a green light for every restriction aimed at transgender Americans just watched a different outcome, because this case turned on whether an agency did its homework. The athlete ruling asked what the law means. The prison order asked whether the government can show its work, and in this case the judge found it could not.
That is the part worth holding onto. The administration did not lose because the Court endorsed a view of gender medicine. It lost because the Bureau wrote a policy copied from an executive order, cited none of its own evidence, and then asked the justices to treat the result as an emergency. Two justices would have let it proceed anyway, which would have started a rapid hormone discontinuation for newly treated inmates while a judge’s pretext finding sat unresolved. We think seven of nine justices not doing that is the correct outcome, and the more telling number is the two.